Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back

The Drug-Induced Respiratory Disease Website and App

XVII.w

XVII - Infections & related conditions

Hypogammaglobulinemia - Antibody deficiency

Last update 17/06/2026

Can be conducive to sytemic and/or pulmonary infections including pneumonia and secondary bronchiolitis and/or bronchiectasis (See also under IVk). Augmentaiion therapy can be indicated (PMID 28852483)

Causative drugs

7

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Anticonvulsants
I.c
II.b
V.b
X.a
X.b
X.y
XI.ab
XVII.w
Corticosteroids, systemic (oral, parenteral)
I.y
II.a
II.d
III.a
III.b
IV.f
VI.a
VI.e
VI.ad
VII.c
VII.g
VII.h
VII.j
VIII.g
IX.a
IX.f
IX.m
IX.p
IX.v
X.f
X.n
X.as
X.ba
XI.v
XI.ag
XI.ai
XI.at
XII.a
XII.l
XII.v
XVI.at
XVI.au
XVII.a
XVII.b
XVII.c
XVII.d
XVII.e
XVII.g
XVII.j
XVII.m
XVII.o
XVII.r
XVII.v
XVII.w
XVII.ai
Fludarabine
I.a
I.b
I.c
I.d
I.e
I.f
I.k
I.l
I.m
II.b
III.a
V.i
XV.c
XV.d
XVII.b
XVII.e
XVII.w
Imatinib
I.a
I.b
I.c
I.d
I.m
I.n
I.y
II.b
II.d
III.a
V.a
V.c
V.i
V.m
V.ah
X.a
X.n
X.r
XII.a
XII.c
XII.f
XIII.g
XV.a
XV.c
XV.n
XV.ch
XVII.g
XVII.h
XVII.o
XVII.w
Penicillamine
I.a
I.b
I.c
I.d
I.w
II.b
III.a
III.b
III.d
IV.a
IV.c
IV.n
V.a
IX.a
IX.r
X.d
X.e
X.j
X.s
X.ac
XI.t
XV.z
XVII.w
Rituximab
I.a
I.b
I.d
I.g
I.l
I.v
II.a
II.b
II.i
III.a
III.c
IV.a
IV.c
IV.d
IV.f
IV.j
IV.k
IV.ak
VII.g
VIII.x
IX.t
IX.ab
X.b
X.f
X.g
X.k
X.n
X.s
X.ao
XI.n
XII.f
XII.g
XV.c
XV.j
XVII.a
XVII.b
XVII.e
XVII.g
XVII.m
XVII.q
XVII.w
XIX.a
XXI.c
Sulfasalazine
I.a
I.b
I.c
I.d
I.g
I.m
II.d
IV.y
V.a
V.b
V.d
V.m
VI.d
VII.a
X.a
X.d
X.g
X.k
X.s
X.u
XI.b
XI.c
XII.c
XII.d
XII.h
XIV.a
XV.c
XV.e
XV.f
XV.k
XV.ac
XVII.w
XIX.a
XIX.c